Fennec Pharmaceuticals Inc. (FENC) Social Stream

Featured Post From StockTwits About FENC

$FENC Another very constructive chart. PDUFA for Pedmark (Cisplatin-Induced Hearing Loss) coming up on NOV 27th. Pedmark received a CRL back in AUG 2020 due to CMC issues, manufacturing facility deficiencies. No issues regarding safety or efficacy. Pedmark could be the first and only approved therapy for this indication of high unmet medical need.